Search
DCH Auriga - Healthcare
DCH Auriga - Healthcare

CSTONE PHARM (HK) HOLDING LTD

Featured products of CStone
Ayvakit
Ayvakit FC tab 100 mg
avapritinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX18 - avapritinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Ayvakit FC tab 300 mg
avapritinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX18 - avapritinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Gavreto
Gavreto hard cap 100 mg
pralsetinib
Packing/Price
120's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX23 - pralsetinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Distributed by DCH Auriga - Healthcare
Ayvakit
Ayvakit FC tab 100 mg
avapritinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX18 - avapritinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Ayvakit FC tab 300 mg
avapritinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX18 - avapritinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Gavreto
Gavreto hard cap 100 mg
pralsetinib
Packing/Price
120's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX23 - pralsetinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Marketed by DCH Auriga - Healthcare
Ayvakit
Ayvakit FC tab 100 mg
avapritinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX18 - avapritinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Ayvakit FC tab 300 mg
avapritinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX18 - avapritinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Gavreto
Gavreto hard cap 100 mg
pralsetinib
Packing/Price
120's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX23 - pralsetinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in